Tag: DEA Regulations

The arrest of telehealth executives accused of overprescribing Adderall showcases the ongoing tension between innovation in telemedicine and regulatory oversight. As digital health solutions gain popularity, they face increasing scrutiny for compliance with medical standards and potential misuse. This scenario also highlights the complex landscape of prescription stimulant medications, their potential for both therapeutic benefit…